- Citations, last 5 years
- 2 490
- Works, last 5 years
- 440
- h-index
- 112
- Scientists listed
- 0
- Grants since 2016
- 3 213
Grants received
2022–2027 · cooperative agreement · UM1
Center for scalable knockout and multimodal phenotyping in genetically diverse human genomes
Danwei Huangfu · Kettering University · funded by National Institutes of Health
2022–2026 · research · R37
Immune control and genomic instability at micronuclei
John Maciejowski · Kettering University · funded by National Institutes of Health
2022–2027 · career development · K08
Defining the role of developmental context in oncohistone-driven gliomagenesis
Maya Srikanth Graham · Kettering University · funded by National Institutes of Health
2022–2029 · research · R35
Regulated cell death and responses to starvation in cancer
Michael H. Overholtzer · Kettering University · funded by National Institutes of Health
2022–2027 · career development · K08
Optimizing Smoking Cessation Treatment for Patients with Bladder Cancer
Richard Steven Matulewicz · Kettering University · funded by National Institutes of Health
2022–2027 · research · R01
Safer lung cancer radiotherapy delivery using novel artificial intelligence methods
Harini Veeraraghavan · Kettering University · funded by National Institutes of Health
2022–2027 · research · R01
Flexible versus Standard Aerobic Training Dosing in Primary Breast Cancer: A Randomized and Response-Adapted Trial
Jessica Scott · Kettering University · funded by National Institutes of Health
2022–2029 · research · R35
Regulated cell death and responses to starvation in cancer
Michael H. Overholtzer · Kettering University · funded by National Institutes of Health
2022–2027 · grant · DP5
Regulation of Proinflammatory Cytokine Responses by a Caspase-8-N4BP1 Axis
Alexander Gitlin · Kettering University · funded by National Institutes of Health
2022–2026 · research · R01
Digital Technology to Enhance Access to and Effectiveness of Cancer Genetic Counseling
Jada Gabrielle Hamilton · Kettering University · funded by National Institutes of Health
2022–2027 · research · R01
Molecular origins and impact of APOBEC3 mutagenesis in cancer
John Maciejowski · Kettering University · funded by National Institutes of Health
2022–2027 · research · RF1
[18F]-PU-AD epichaperome PET imaging probe
Gabriela Chiosis · Kettering University · funded by National Institutes of Health
2022–2026 · research · R01
Genomic biomarkers of splenic lymphoma
Kojo S. J. Elenitoba-Johnson · Kettering University · funded by National Institutes of Health
2022–2027 · research · R01
Minimizing salivary gland and renal toxicity arising from PSMA-targeted alpha therapy
Nagavarakishore Pillarsetty · Kettering University · funded by National Institutes of Health
2022–2027 · grant · DP5
Regulation of Proinflammatory Cytokine Responses by a Caspase-8-N4BP1 Axis
Alexander Gitlin · Kettering University · funded by National Institutes of Health
2022–2027 · research · R01
Identifying senescence and immune biomarkers predictive of benefit to combined CDK4 and checkpoint blockade inhibition in patients with dedifferentiated liposarcoma
Sandra P D'Angelo · Kettering University · funded by U.S. Food and Drug Administration
2022–2027 · research · R37
Understanding the Importance of Industry Relationships for Cancer Care Quality, Outcomes, and Costs
Aaron P Mitchell · Kettering University · funded by National Institutes of Health
2022–2027 · research · R01
Molecular mechanisms of gamma-secretase modulation central to Alzheimer’s disease
Liang Feng · Kettering University · funded by National Institutes of Health
2022–2027 · research · R01
Flexible versus Standard Aerobic Training Dosing in Primary Breast Cancer: A Randomized and Response-Adapted Trial
Jessica Scott · Kettering University · funded by National Institutes of Health
2022–2027 · career development · K08
Optimizing Smoking Cessation Treatment for Patients with Bladder Cancer
Richard Steven Matulewicz · Kettering University · funded by National Institutes of Health
2022–2027 · grant · D43
Expanding cancer research capacity in Nigeria with team science
T Peter Kingham · Kettering University · funded by National Institutes of Health
2022–2027 · research · R01
Ferroptosis and Cancer Cell Signaling
Xuejun Jiang · Kettering University · funded by National Institutes of Health
2022–2027 · research · RF1
[18F]-PU-AD epichaperome PET imaging probe
Gabriela Chiosis · Kettering University · funded by National Institutes of Health
2022–2029 · research · R35
Regulated cell death and responses to starvation in cancer
Michael H. Overholtzer · Kettering University · funded by National Institutes of Health
2022–2026 · research · R01
Mechanisms of enhancer-promoter communication, genome organization and transcription control
Alexandros Pertsinidis · Kettering University · funded by National Institutes of Health
2022–2027 · research · R01
Group 2 Innate Lymphoid Cell Regulation of Pancreatic Cancer Immunity
Vinod P Balachandran · Kettering University · funded by National Institutes of Health
2022–2027 · research · R01
Integration of Imaging and Circulating Plasma Cell-Free DNA Sequencing Using MSK-ACCESS to Monitor Treatment Response and Predict Progression in Patients With Multiple Cancers on Targeted Therapy
Michael F. Berger · Kettering University · funded by National Institutes of Health
2022–2027 · career development · K08
Role of Fc Receptors in the Therapeutic Activity of Antibodies Targeting the CD47-SIRP-alpha axis
Juan C Osorio · Kettering University · funded by National Institutes of Health
2022–2027 · research · R01
Prolidase Inhibitors as Therapeutic Agents for Acute Myeloid Leukemia
Daniel Bachovchin · Kettering University · funded by National Institutes of Health
2022–2027 · cooperative agreement · U01
Dose-response of aerobic training during total neoadjuvant therapy for locally advanced rectal cancer
Andrea Cercek · Kettering University · funded by National Institutes of Health
2022–2026 · research · R01
Structure-Activity Based Mechanistic Insights into Cleavage Chemistry by Self-Cleaving Nucleolytic Ribozymes
Dinshaw J Patel · Kettering University · funded by National Institutes of Health
2022–2026 · career development · K00
Investigating the Role of Cell Plasticity in Malignant Transformation
Andrea Christine Chaikovsky · Kettering University · funded by National Institutes of Health
2022–2027 · research · R50
Developing therapeutic TCR mimic monoclonal antibodies for cancer
Tao Dao · Kettering University · funded by National Institutes of Health
2022–2026 · career development · K08
Assessing lineage infidelity, oncogenic cooperativity and dependency in RUNX1-mutant acute myeloid leukemia
Wenbin Xiao · Kettering University · funded by National Institutes of Health
2022–2027 · cooperative agreement · U24
The cBioPortal for Cancer Genomics
Jianjiong Gao · Kettering University · funded by National Institutes of Health
2022–2027 · cooperative agreement · UM1
Center for scalable knockout and multimodal phenotyping in genetically diverse human genomes
Danwei Huangfu · Kettering University · funded by National Institutes of Health
2022–2027 · research · R37
Discovery and characterization of clinically actionable germline mutations in DNA damage repair (DDR) pathway genes in lung cancer
Semanti Mukherjee · Kettering University · funded by National Institutes of Health
2022–2027 · research · R01
Structural and functional principles underlying germline genome transmission
Scott Keeney · Kettering University · funded by National Institutes of Health
2022–2026 · research · R35
Regulation of protein multi-functionality by 3 UTRs
Christine Mayr · Kettering University · funded by National Institutes of Health
2022–2027 · program · P50
Determining the mechanism of pks+ E.coli-associated carcinogenesis in early onset colorectal cancer.
Christine A Iacobuzio-Donahue · Kettering University · funded by National Institutes of Health